iRadimed (IRMD)
(Delayed Data from NSDQ)
$44.40 USD
-1.75 (-3.79%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $44.26 -0.14 (-0.32%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/1/24 |
---|---|
Current Quarter | 0.38 |
EPS Last Quarter | 0.42 |
Last EPS Surprise | 16.67% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 1.54 |
Next Year | 1.75 |
EPS (TTM) | 1.60 |
P/E (F1) | 28.83 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | 20.20M | 73.09M | 82.24M |
# of Estimates | NA | 1 | 1 | 1 |
High Estimate | NA | 20.20M | 73.09M | 82.24M |
Low Estimate | NA | 20.20M | 73.09M | 82.24M |
Year ago Sales | 16.51M | 17.45M | 65.56M | 73.09M |
Year over Year Growth Est. | NA | 15.76% | 11.48% | 12.52% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.38 | 0.43 | 1.54 | 1.75 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | 0.38 | 0.43 | 1.54 | NA |
High Estimate | 0.38 | 0.43 | 1.54 | 1.75 |
Low Estimate | 0.38 | 0.43 | 1.54 | 1.75 |
Year ago EPS | 0.43 | 0.39 | 1.48 | 1.54 |
Year over Year Growth Est. | -11.63% | 10.26% | 4.05% | 13.64% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.38 | 0.43 | 1.54 | 1.75 |
7 Days Ago | 0.38 | 0.43 | 1.54 | 1.75 |
30 Days Ago | 0.38 | 0.43 | 1.54 | 1.75 |
60 Days Ago | 0.38 | 0.43 | 1.54 | 1.75 |
90 Days Ago | 0.38 | 0.43 | 1.54 | 1.75 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.38 | 0.43 | 1.54 | 1.75 |
Zacks Consensus Estimate | 0.38 | 0.43 | 1.54 | 1.75 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.42 | 0.36 | 0.39 | 0.43 | NA |
Estimate | 0.36 | 0.34 | NA | 0.37 | NA |
Difference | 0.06 | 0.02 | NA | 0.06 | 0.05 |
Surprise | 16.67% | 5.88% | NA | 16.22% | 12.92% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more